Moderna
MRNA
#1047
Rank
ยฃ17.60 B
Marketcap
ยฃ44.08
Share price
0.65%
Change (1 day)
132.70%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -ยฃ2.32 Billion

According to Moderna 's latest financial reports the company's current earnings are ยฃ2.20 Billion. In 2025 the company made an earning of -ยฃ2.05 Billion, an increase over its 2024 earnings that were of -ยฃ2.66 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ2.32 Billion13.44%
2025 -ยฃ2.05 Billion-23.03%
2024 -ยฃ2.66 Billion-8.22%
2023 -ยฃ2.89 Billion-140.65%
2022 ยฃ7.10 B-27.81%
2021 ยฃ9.84 B-1911.15%
2020 -ยฃ0.55 Billion44.7%
2019 -ยฃ0.38 Billion28.63%
2018 -ยฃ0.3 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.23 B-934.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ11.68 B-607.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
ยฃ9.73 B-522.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-ยฃ35.11 Million-98.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-ยฃ87.1 Million-96.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ30.92 Million-98.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ0.64 B-127.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-ยฃ0.12 Billion-94.86%๐Ÿ‡บ๐Ÿ‡ธ USA